基础医学与临床 ›› 2018, Vol. 38 ›› Issue (9): 1286-1291.

• 研究论文 • 上一篇    下一篇

银胶菊内酯减轻氧糖剥夺/再恢复诱导的PC12细胞损伤

张军峰,徐曦,徐仓宝,张一博,房智超,郝佳晖,赵朝华   

  1. 西安医学院
  • 收稿日期:2018-03-26 修回日期:2018-06-21 出版日期:2018-09-05 发布日期:2018-09-10
  • 通讯作者: 赵朝华 E-mail:453530531@qq.com
  • 基金资助:
    陕西省缺血性心血管疾病重点实验室开放基金项目;陕西省大学生创新训练项目;西安医学院国科金培育基金;西安医学院配套基金项目;陕西省优势学科建设经费资助;陕西省教育厅科研项目

Parthenolide alleviates oxygen-glucose deprivation/reperfusion-induced ischemic injury in PC12 cells

  • Received:2018-03-26 Revised:2018-06-21 Online:2018-09-05 Published:2018-09-10

摘要: 目的 探讨银胶菊内酯(PN)对脑缺血/再灌注(I/R)损伤的神经保护作用及可能机制。方法 将外培养的PC12细胞分为对照组、氧-糖剥夺-再灌注(OGD/R)组及PN预处理组(1、5、10和20 μmol/L,各组n=3)。CCK-8检测细胞活力,试剂盒检测caspase-3、过氧化氢(H2O2)酶、超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)的活性及乳酸脱氢酶(LDH)、活性氧(ROS)。Western blot检测Bcl-2、Bax、p-Akt/Akt和p-GSK-3β/GSK-3β蛋白表达。结果 与对照组相比,OGD/R组PC12细胞活力、LDH和ROS含量、Bcl-2表达平、Akt和GSK-3β的磷酸化水平及H2O2酶、SOD和GPx的活性均明显下降(P<0.05);ROS含量、Bax-1表达量和caspase-3活性均明显升高(P<0.05);与OGD/R组相比,PN预处理能显著缓解以上变化(P<0.05)。结论 PN可以作为一种潜在的治疗脑I/R损伤的药物。

关键词: 银胶菊内酯, 脑缺血/再灌注, 氧-葡萄糖剥夺, Akt/GSK-3β信号通路

Abstract: Objective To explore the neuroprotective effects of PN against ischemia/reperfusion (I/R) induced injuries and the underlying mechanisms. Methods PC12 cells were cultured in vitro, and divided into culture group, the oxygen-glucose deprivation and reperfusion (OGD/R) group, and PN group (1, 5, 10 and 20 μmol/L, n=3 in each group). CCK-8 assay was used to detect the cell viability. Using the kits, the activities of caspase-3, catalase, superoxide dismutase (SOD) and glutathione peroxidase (GPx), and the levels of lactic dehydrogenase (LDH) and reactive oxygen spices (ROS) were determined. The protein expression of Bcl-2, Bax, p-Akt/Akt and p-GSK-3β/GSK-3β were detected using western blot. Results Compared with control group, the PC12 cells viability , the activities of catalase, SOD and GPx, and the levels of LDH, ROS, Bcl-2, and phosphorylation of Akt and GSK-3β were significantly decreased in the OGD/R group (P<0.05), with increased level of ROS, Bax-1 expression and caspase-3 activity (P<0.05). But PN treatment could significantly alleviate these changes in PC12 cells, compared with OGD/R group (P<0.05). Conclusions PN is a potential therapy for the cerebral I/R injury.

Key words: Parthenolide (PN), cerebral ischemia/reperfusion (I/R), oxygen-glucose deprivation (OGD), Akt/GSK-3β signal pathway

中图分类号: